Quince Therapeutics (QNCX) renamed IRulya Therapeutics, new ticker IRLA effective Oct 12. New CEO, CFO, COO. Cash $116M funds through 2028. Phase 2 data readouts for LAM-001 in BOS (Q1 2027), PH-ILD (Q1 2028), SAPH (Q4 2028).
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
